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Type 2 innate lymphoid cells (ILC2s) promote anti-
helminth responses and contribute to allergies.
Here, we report that Bcl11b, previously considered
a T-cell-specific transcription factor, acted directly
upstream of the key ILC2 transcription factor Gfi1
to maintain its expression in mature ILC2s. Conse-
quently, Bcl11b/ ILC2s downregulated Gata3 and
downstream genes, including Il1rl1 (encoding IL-33
receptor), and upregulated Rorc and type 3 ILC
(ILC3) genes. Additionally, independent of Gfi1,
Bcl11b directly repressed expression of the gene
encoding the ILC3 transcription factor Ahr, further
contributing to silencing of ILC3 genes in ILC2s.
Thus, Bcl11b/ ILC2s lost their functions and
gained ILC3 functions, and although they expanded
in response to the protease allergen papain, they
produced ILC3 but not ILC2 cytokines and caused
increased airway infiltration of neutrophils instead
of eosinophils. Our results demonstrate that Bcl11b
is more than just a T-cell-only transcription factor
and establish that Bcl11b sustains mature ILC2 ge-
netic and functional programs and lineage fidelity.
INTRODUCTION
Innate lymphoid cells (ILCs) reside at mucosal sites, produce
T-helper-cell-like cytokines and play a critical role in maintaining
mucosal homeostasis and preventing pathogen invasion. Type 2
ILCs (ILC2s) respond to interleukin-33 (IL-33), IL-25, and thymic
stromal lymphopoietin (TSLP) produced by damaged lung
epithelial tissue after viral and helminth infections or allergic re-
actions. ILC2s produce IL-13 and IL-5 and contribute to mucus
secretion and accumulation of eosinophils in the airway and
inflammation (Bartemes et al., 2012; Chang et al., 2011; Halim
et al., 2012b). ILC2s also produce amphiregulin, promoting
airway epithelial repair during viral infections (Monticelli et al.,
2011). ILC2s are controlled by the transcription factors Gata3,
Rora, TCF-1, and Gfi1 (Halim et al., 2012b; Hoyler et al., 2012;354 Immunity 43, 354–368, August 18, 2015 ª2015 Elsevier Inc.Spooner et al., 2013; Wong et al., 2012; Yang et al., 2013). In
contrast to ILC2s, ILC3s are normally excluded from the lung.
They express the transcription factors Rorgt and aryl hydrocar-
bon receptor (Ahr), absent in ILC2s, and produce the T helper
17 (Th17)-cell-associated cytokines IL-17 and IL-22 (Cella
et al., 2009; Halim et al., 2012b; Kiss et al., 2011; Qiu et al.,
2012). In the gut, ILC3-derived IL-22 induces repair of the gut
epithelium and production of anti-microbial peptides (Luci
et al., 2009; Sawa et al., 2011; Sonnenberg et al., 2012). ILC2s
and ILC3s are dependent in their development on Id2 and Notch
signaling (Cherrier et al., 2012; Lee et al., 2012; Possot et al.,
2011), as well as on Gata3 and TCF-1 (Halim et al., 2012b; Hoyler
et al., 2012; Mielke et al., 2013; Serafini et al., 2014; Wong et al.,
2012; Yang et al., 2013). Gata3 is also responsible for the expres-
sion of the ILC2 cytokine-encoding genes Il5 and Il13, as well as
of the IL-33 receptor (ST2), encoded by Il1rl1 (Hoyler et al., 2012;
Yagi et al., 2014). TCF-1 is positioned upstream of Gata3 in
the control of ILC2 lineage development (Yang et al., 2013).
Another transcription factor, Gfi1, controls ILC2 development,
and its absence is associated with reduced Gata3 expression,
concomitant with derepression of the ILC3 transcription-factor-
encoding gene Rorc and increased IL-17 production (Spooner
et al., 2013).
Bcl11b is a C2H2 transcriptional regulator (Avram et al., 2000;
Avram et al., 2002) that functions as both a transcriptional acti-
vator and repressor (Cismasiu et al., 2005; Cismasiu et al.,
2006). Its expression is initiated at the thymic DN2 stage, and it
remains expressed in all mature T lymphocytes. Bcl11b is impor-
tant for T lineage differentiation and T cell identity (Albu et al.,
2007; Li et al., 2010a; Li et al., 2010b; Wakabayashi et al.,
2003). Bcl11b also controls mature cytotoxic T lymphocyte
(CTL) function, restricts Th17 cell plasticity toward a Th2 cell
phenotype, controls suppression function of T regulatory (Treg)
cells, and invariant natural killer (NK) T cell development (Albu
et al., 2007; Albu et al., 2011; Califano et al., 2014; Li et al.,
2010a; Li et al., 2010b; Uddin et al., 2014; Vanvalkenburgh
et al., 2011; Zhang et al., 2010). Given that ILC2 development re-
lies on the same regulators that are critical for T cell develop-
ment, including Notch, TCF-1, Gata3, and Gfi1 (Hoyler et al.,
2012; Spooner et al., 2013; Yang et al., 2013), and because
Bcl11b transcripts are found highly expressed in ILC2s (Yang
et al., 2013), we investigated its role in these cells. Although
Bcl11bwas not required for ILC2 development, and the numbers
of mature ILC2s (mILC2s) remained normal in the absence of
Bcl11b, Bcl11b/ ILC2s downregulated ST2 and the critical
transcription factors for ILC2 lineage Gfi1, Gata3, and Rora
and acquired expression of the ILC3 lineage transcription factors
Rorgt and Ahr, as well as the receptor for IL-23. Bcl11b/ ILC2s
expanded similarly to wild-type ILC2s in response to the prote-
ase allergen papain but produced ILC3-type cytokines, resulting
in reduced mucus production and increased airway infiltration of
neutrophils instead of eosinophils, usually associated with the
response to protease allergens. Our study thus demonstrates
that Bcl11b maintains identity and function of mILC2s, changing
the notion that Bcl11b is a T-cell-specific transcription factor.
RESULTS
Bcl11b Is Present in High Amounts in the Peripheral
ILC2 Populations
Given thatBcl11b transcripts are expressed in ILC2s (Yang et al.,
2013), we first evaluated Bcl11b in ILC2s, defined as LinCD90+
CD127+ST2+ (Monticelli et al., 2011), and in ILC3s (LinCD90+
CD127+Rorgt+) (Halim et al., 2012b; Monticelli et al., 2011).
Whereas a large percentage of the lung and mesenteric lymph
node (mLN) ILC2s showed high amounts of Bcl11b (Figures
S1A and S1B), only a small percentage of the mLN ILC3s were
positive for Bcl11b, and the amount was lower than in ILC2s (Fig-
ures S1A and S1B). In the bone marrow (BM) ILC2 precursors
(ILC2Ps; LinCD127+Sca-1hicKitST2+), the amount of Bcl11b
was close to background amounts in both the Klrg1hi and Klrglo
populations (Figure S1F). Given these results, we further focused
our studies on the role of Bcl11b in mILC2s.
Bcl11b–/– ILC2s Have Reduced ST2
To remove Bcl11b in the ILC2s, we utilized the inducible cre-
estrogen receptor T2 (cre-ERT2), in which estrogen receptor 1
(ESR1) has a mutation, making it highly responsive to tamoxifen
treatment (TMX) (Figure S1C). Given that Klrg1 was previously
identified as amarker for mILC2s (Hoyler et al., 2012), we defined
peripheral mILC2s as LinCD90+CD127+Sca-1+Klrg1hi (Figures
1A–1C). Of note, the vast majority of LinCD90+CD127+
Sca-1+Klrg1hi cells were ST2+Gata3+Rorgt- in wild-type mice
(Figures 1D, 1F, and 1G), supporting the idea that these cells
indeed represent the mILC2 population, whereas LinCD90+
CD127+Sca-1+Klrg1lo cells were Rorgt+ and hence ILC3s (Fig-
ure S2). Lung, mLN, and small intestine lamina propria (SILP)
Bcl11b/ mILC2s were similar in percentages and absolute
numbers to wild-type ILC2s (Figures 1A–1C and Figure S3A);
however, Bcl11b/ mILC2s exhibited a marked reduction in
ST2 (Figure 1D), but not in IL-17Rb, a subunit of the IL-25 recep-
tor (IL-25R) (Figure S4A). Of note, Bcl11bwas efficiently removed
in the mILC2s of TMX-treated Bcl11bF/Fcre-ERT2 mice (Fig-
ure S1D), except in the subpopulation of cells that still main-
tained ST2 (Figure S1E). These results demonstrate that
Bcl11b deficiency does not cause the loss of mILC2s but instead
results in reduction of ST2, but not IL-17Rb.
Bcl11b Does Not Control Development or Maturation
of ILC2Ps in the BM
As shown above, the amount of Bcl11bwas close to background
in the BM ILC2Ps (Figure S1F). Supporting this observation,there was no difference in the LinCD127+Sca-1hi cKitST2+
ILC2Ps or in the Klrg1lo or Klrg1hi populations in the BM of
TMX-Bcl11bF/Fcre-ERT2 and TMX-Bcl11bF/F mice (Figures
S5A–S5C). We evaluated the response of BM ILC2Ps to IL-33
treatment, known to promote maturation of these progenitors
(Spooner et al., 2013), and this treatment caused a similar in-
crease in the numbers of BM ST2hiKlrg1hi ILC2s in both groups
of mice (Figure S5D), demonstrating that Bcl11b deficiency did
not restrict maturation of the ILC2 lineage.
Bcl11b–/– ILC2s Have Reduced Gata3 and Rora
and Upregulate the ILC3-Specific Transcription
Factor Rorgt and the IL-23 Receptor
Considering that ST2 expression is controlled by Gata3 in ILC2s
(Hoyler et al., 2012), we further investigated Gata3. As expected,
the wild-type mILC2 population showed high Gata3 and Rora
amounts in the lung, mLNs, and SILP and did not express the
ILC3 lineage transcription factor Rorgt (Figures 1F and 1G and
Figures S3B and S3C), which conversely was expressed in the
ILC3 population (Figure S2). Different from wild-type mice,
TMX-Bcl11bF/Fcre-ERT2 mice had a major reduction in the
Gata3hi and Rora+ mILC2 population in the lung, mLNs, and
SILP, in favor of a Gata3loRorgt+ population (Figures 1F–1I and
Figures S3B and S3C). Additionally, Bcl11b/mILC2s exhibited
asignificant reduction inGata3meanfluorescence intensity (MFI),
whereas the Rorgt MFI was increased (Figures 1J and 1K) even in
the lung tissue, where ILC3s are restricted at steady state (Halim
et al., 2012b). Bcl11b/ mILC2s showed not only increased
Rorgt but also increased IL-23 receptor (IL-23R) (Figure 1E), nor-
mally expressed in ILC3s (Buonocore et al., 2010). Expression of
Gata3 and Rorgt in the ILC3 population from mLNs of TMX-
Bcl11bF/Fcre-ERT2 mice was equivalent to that in wild-type
mice (Figure S2), indicating that the ILC3s keep their identity in
the absence of Bcl11b. Gata3 was similar in the ILC2Ps from
the BM of both TMX-Bcl11bF/Fcre-ERT2 mice and TMX-
Bcl11bF/F mice, whereas Rorgt was not expressed (Figure S5E),
further indicating that Bcl11b does not control ILC2 identity in
the BM. These results demonstrate that the absence of Bcl11b
in the mILC2 population causes downregulation of the critical
ILC2 lineage factors Gata3, Rora, and ST2 and upregulation of
the ILC3 lineage factors Rorgt and IL-23R and thus results in
loss of identity.
The Shift in ILC2 Identity in the Absence of Bcl11b
Occurs in a T-Cell-Independent Manner
Bcl11b is also expressed in T cells, in which it plays critical roles.
To exclude any implication of T cells in the observed phenotype,
we generated Bcl11bF/Fcre-ERT2 Rag1/ mice, which lack
T and B cells but maintain the ILC populations (Halim et al.,
2012a). As in the T-cell-sufficient mice, the percentages of
mILC2s remained equivalent between TMX-Rag1/Bcl11bF/F
cre-ERT2 and TMX-Rag1/Bcl11bF/F mice (Figure 2A). Also,
as in immunocompetent mice, ST2 was profoundly reduced
in the absence of Bcl11b in the mILC2s (Figure 2B) and so
were the percentages of the Gata3hi mILC2s, in favor of a
Gata3loRorgt+ population (Figure 2C) and indicative of the acqui-
sition of an ILC3 phenotype. These results demonstrate that the
loss of the ILC2 identity and acquisition of the ILC3 phenotype
are caused by a T-cell-independent mechanism.Immunity 43, 354–368, August 18, 2015 ª2015 Elsevier Inc. 355
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Identity Loss and Acquisition of the ILC3 Phenotype
in the Absence of Bcl11b in mILC2s Is Cell Intrinsic
To determine whether the observed phenotype is intrinsic to
mILC2s, we reconstituted sub-lethally irradiated Rag2/Il2rg/
mice, which lack adaptive and innate lymphoid populations,
with sorted BM LinCD127+Sca-1hiST2+ ILC2 precursors from
Bcl11bF/Fcre-ERT2 or Bcl11bF/F mice not treated with TMX. The
TMX treatment was initiated 2.5 weeks after transfer, and the
ILCpopulationswere evaluated 4weeks after transfer for assuring
that the precursors became mILC2s before Bcl11b removal (Fig-
ure S6A). Although the ILC2 precursors were equivalent in the
two groups of reconstituted mice, Bcl11b/ mILC2s were low
in ST2 and upregulated Rorgt, further supporting the notion that
the alterations in the absence of Bcl11b occur in mILC2s (Fig-
ures 2D–2I). To demonstrate that the non-hematopoietic popula-
tions do not participate in the observedphenotype,we transferred
BM LinCD127+Sca-1hiST2+ ILC2 precursors from Bcl11bF/Fcre-
ERT2 or Bcl11bF/F mice not treated with TMX into lethally irradi-
ated Bcl11bF/Fcre-ERT2 or Bcl11bF/F mice (Figure S6B), which
were further treated as described above. Both Bcl11bF/Fcre-
ERT2 and Bcl11bF/F mice reconstituted with ILC2Ps from
Bcl11bF/F donor mice generated mILC2s with high amounts of
ST2 and Gata3 (Figures S6C and S6D), whereas Bcl11bF/Fcre-
ERT2 and Bcl11bF/F mice reconstituted with ILC2Ps from
Bcl11bF/Fcre-ERT2 donor mice generated ST2loGata3loRorgt+IL-
23R+ mILC2s (Figures S6C and S6D), demonstrating that the
loss of ST2 and the shift in the mILC2 identity toward an ILC3
phenotype were not dependent on the non-hematopoietic
compartment of TMX-Bcl11bF/Fcre-ERT2 mice and occurred in
mILC2s. Taken together, these data demonstrate that Bcl11b is
required for maintaining mILC2 identity and blocking expression
of the ILC3 phenotype in mILC2s in a cell-intrinsic manner.
Bcl11b–/– ILC2s Proliferate in Response to IL-23
and IL-25, but Not in Response to IL-33
Bcl11b/mILC2s exhibited a decrease in ST2 concomitant with
an increase in IL-23R (Figures 1D and 1E). We thus investigated
how these cells respond to IL-33 versus IL-23 in terms of prolifer-
ation.Whereaswild-typemILC2s exhibited enhancedBrdU incor-
poration and an increase in their absolute numbers in response to
IL-33 injection (Figures 3A and 3B), Bcl11b/ mILC2s exhibited
minimal BrdU incorporation, and the absolute numbers remained
similar to those from mice injected with PBS (Figures 3A and 3B).
Conversely, IL-23 administration caused increasedBrdU incorpo-Figure 1. Bcl11b’s Removal Causes Reduced ST2, Gata3, and Rora an
(A and B) Flow cytometry analysis of the LinCD90+ (left panel), LinCD9
LinCD90+Sca-1+CD127+Klrg1lo (right panel) populations in the lungs (A) and mL
(C) Absolute numbers of LinCD90+Sca-1+CD127+Klrg1hi mILC2 and LinC
TMX-Bcl11bF/Fcre-ERT2 (black) and TMX-wild-type control (white) mice. Data (
as mean ± SEM. Significance was determined by Student’s t test (*p% 0.05).
(D and E) Surface ST2 (D) and IL-23R (E) were evaluated by flow cytometry in t
TMX-wild-type control (dashed) mice. The gray shaded area represents the nega
(F and G) Flow cytometry analysis of Gata3 and Rorgt (left panel) and CD90 and R
groups of mice.
(H and I) Average frequencies of Gata3+ (H) and Rorgt+Gata3lo (I) mILC2s in the
(J and K) MFI of Gata3 (J) and Rorgt (K) in mILC2s from the lungs and mLNs of t
(H–K) Data (n = 6) are representative of three independent experiments and are
(*p% 0.05).
See also Figures S1–S3 and S5.ration in the Bcl11b/ mILC2s, as well as an increase in their
absolute numbers, which did not occur in wild-type cells (Figures
3A and 3B). Importantly, mILC2s from both TMX-Bcl11bF/Fcre-
ERT2 and TMX-Bcl11bF/F mice injected with IL-25 incorporated
BrdU and underwent proliferative expansion equivalently (Figures
S4B and S4C), in agreement with similar expression of IL-17Rb in
the mILC2s of both groups of mice (Figure S4A). These data
demonstrate that Bcl11b/ mILC2s fail to expand in response
to IL-33and insteadexpand in response to IL-23whilemaintaining
normal expansion in response to IL-25.
Bcl11b–/– ILC2s Produce ILC3 Cytokines in Response
to IL-23, but Not ILC2 Cytokines in Response
to IL-33 or IL-25
We further investigated the cytokine production by Bcl11b/
and wild-type ILC2s in response to IL-33, IL-25, or IL-23 injec-
tions. Wild-type ILC2s produced IL-13 in response to IL-33 or
IL-25 and failed to produce IL-22 or IL-17 in response to IL-23
(Figures 3C–3D and Figures S4D and S4E). Conversely,
Bcl11b/ ILC2s produced IL-22 and IL-17 in response to IL-
23, but not IL-13 in response to IL-33 or IL-25 (Figures 3C–3D
and Figures S4D and S4E). These results demonstrate that
Bcl11b/ ILC2s produce ILC3 cytokines in response to IL-23
stimulation, but not ILC2 cytokines in response to IL-33 or IL-
25. Additionally, even though Bcl11b/ ILC2s had normal IL-
17Rb and proliferated in response to IL-25, they failed to produce
IL-13 in response to this cytokine (Figures S4D and S4E), sug-
gesting alterations in factors that control ILC2 cytokine produc-
tion, although the expansion pathwaymost likely remained intact.
Bcl11b–/– ILC2s Respond by an ILC3 Type of Airway
Inflammation to the Protease Papain
ILC2s have been previously shown to play a critical role in
the response to protease-induced airway inflammation (Halim
et al., 2012a; Wilhelm et al., 2011). As expected, intranasal
administration of the protease allergen papain induced the pro-
duction of the ILC2 cytokines IL-5 and IL-13 in the lungs of
wild-type mice, whereas the production of these cytokines was
reduced in TMX-Bcl11bF/Fcre-ERT2 mice, which instead pro-
duced the ILC3 cytokines IL-17 and IL-22 (Figures 4A and 4B).
Importantly the Bcl11b/ ILC2s expanded similarly to wild-
type ILC2s after administration of papain (Figure 4C). Related
to the elevated production of IL-17 and decreased production
IL-5, increased neutrophil numbers were observed in the lungsd Increased Rorgt in mILC2s
0+Sca-1+CD127+ (central panel), and LinCD90+Sca-1+CD127+Klrg1hi and
Ns (B) of TMX-Bcl11bF/Fcre-ERT2 and TMX-wild-type control mice.
D90+Sca-1+CD127+Klrg1lo ILC3 populations in the lungs and mLNs of
n = 7) are representative of four independent experiments and are presented
he mILC2s from the lungs and mLNs of TMX-Bcl11bF/Fcre-ERT2 (black) and
tive control.
ora (right panel) in the mILC2s from the lungs (F) and mLNs (G) of the indicated
lungs and mLNs of the indicated groups of mice.
he indicated groups of mice.
presented as mean ± SEM. Significance was determined by Student’s t test
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and bronchoalveolar lavage fluid (BALF) of TMX-Bcl11bF/Fcre-
ERT2 mice, but the numbers of eosinophils were reduced, con-
trary to the response of the wild-type mice, which showed
increased eosinophils and less evident neutrophils (Figure 4D).
We further evaluated mucus production in response to IL-13
and found that the lungs of TMX-Bcl11bF/Fcre-ERT2 mice
treated with papain exhibited less mucus production than did
those of wild-type mice (Figure 4E). These data demonstrate
that similar to wild-type cells, Bcl11b/ ILC2s in the lungs
respond to papain by expanding; however, they produce the
ILC3 cytokines IL-17 and IL-22, causing increased neutrophil
numbers. In addition, Bcl11b/ ILC2s exhibit a reduced ability
to produce ILC2 cytokines, which thus results in diminished
mucus production and reduced eosinophils. These results
further support the idea that Bcl11b/ ILC2s are functionally
shifted to an ILC3 phenotype.
Small Intestine Bcl11b–/– ILC2s Produce ILC3 Cytokines
after Infection with Citrobacter rodentium, Conferring
Increased Protection to Infection
IL-22 and IL-17 produced by ILC3s play a critical role in the early
response to infection with Citrobacter rodentium (Qiu et al.,
2012). Given that Bcl11b/ ILC2s behave as ILC3s during
papain-induced asthma, we investigated their response after
C. rodentium infection. Mice bearing Bcl11b/ ILC2s had
reduced bacterial burden on post-infection day 5, associated
with increased IL-22 and IL-17 production by small intestine
and mLN ILC2s (Figures 4F–4H). The response of Bcl11b/
ILC2s was similar to that of wild-type mILC3s (Figures 4G and
4H). Thus,Bcl11b/ ILC2s together with ILC3s efficiently partic-
ipate in the protective response to C. rodentium.
Bcl11b Sustains Expression of Key ILC2 Genes and
Blocks Expression of Critical ILC3 Genes in ILC2s
To establish the molecular functions of Bcl11b in mILC2 lineage,
we performed RNA-sequencing (RNA-seq) analysis on sorted
ILC2s (LinCD90+Klrg1+) from the mLNs of TMX-Bcl11bF/Fcre-
ERT2mice and TMX-wild-type controls at steady state. The anal-
ysis revealed a downregulated broad ILC2 genetic program,
including the mRNAs for Il1rl1 (encoding ST2), its coreceptor
Il1rap, and importantly, the transcription factor gene Gfi1 (Fig-
ure 5A), known to sustain the ILC2 genetic program and repress
the ILC3 genetic program (Spooner et al., 2013). Additionally,
mRNA for Gata3, known to be a downstream target of Gfi1, wasFigure 2. The Phenotypic Alterations of Bcl11b–/– mILC2s Are T Cell In
(A) Flow cytometry analysis of the mILC2s and ILC3s in the lungs and mLNs of T
(B) Flow cytometry analysis of surface ST2 in the mILC2s from the lungs and mLN
The gray shaded area represents the negative control.
(C) Gata3 and Rorgt were evaluated by flow cytometry in the mILC2s from the lun
three independent experiments.
(D) Flow cytometry analysis of LinCD90+Sca-1+CD127+ ILCs in the lungs
(LinCD127+Sca-1hiST2+) from Bcl11bF/Fcre-ERT2 or wild-type mice. Of note,
recipient mice 2.5 weeks after transfer, as described in Figure S6A.
(E and F) Surface ST2 (E) and average frequency of ST2+ cells (F) in the LinC
reconstituted as in (D) with BM ILC2Ps from the indicated groups of mice. The g
(G–I) Rorgt (G), average frequency of Rorgt+ cells (H), and average MFI of Rorg
indicated groups of mice. Data (n = 5) are representative of two independent exp
Student’s t test (*p% 0.05).
See also Figure S6.also mildly downregulated in Bcl11b/ mILC2s (Figure 5A), and
when evaluated by qRT-PCR, it was significantly altered (Fig-
ure 5B). Tcf7 mRNA, encoding TCF-1, also known to regulate
Gata3 (Spooner et al., 2013; Weber et al., 2011), had only a minor
decrease and was not significant when evaluated by qRT-PCR
(Figures 5A and 5B), suggesting that Bcl11b is most likely posi-
tioned upstream of Gfi1 and Gata3, but not Tcf7. RoramRNA re-
mained unchanged (data not shown) even though Rora was
severely reduced (Figures 1F and 1G), suggesting that Rora is
regulated through an alternativemechanism. Related to this,Dro-
sha mRNA was highly upregulated in Bcl11b/ mILC2s (Fig-
ure 5A), suggesting the possibility of an increase in microRNAs
and thereby post-transcriptional regulation of ILC2 genes. The
gene encoding amphiregulin (Areg), which is produced by ILC2s
after influenza infection (Monticelli et al., 2011), was also upregu-
lated in Bcl11b/ mILC2s (Figure 5A), suggesting that Bcl11b
might play an inhibitory role for this gene. In addition, a broad
ILC3 genetic program (Cherrier et al., 2012; Mortha et al., 2014;
Sonnenberg et al., 2011) including transcripts for Rorc, Ahr,
Il23r, Il22, Cxcl3, Cxcl2, Ccr6, Ltbr, and Csf2 (encoding GM-
CSF) (Figure 5A) was upregulated. Furthermore, similar to that in
Gfi1/ ILC2s, expressionofSox4wasmarginally but significantly
upregulated (Figures 5A and 5B). Importantly, and unlike that in
Gfi1/ ILC2s, AhrmRNA was highly upregulated (Figure 5A). Of
note, in Gfi1/ ILC2s, Ahr was downregulated. Furthermore,
Bcl11b/ mILC2s upregulated transcripts for major histocom-
patibility complex (MHC) class II genes H2-Aa and H2-Ab1 (Fig-
ure 5A), expressed in both ILC3s and ILC2s (Hepworth et al.,
2013; Oliphant et al., 2014). Consistent with lower expression of
Notchsignalingcomponents in ILC3s (Cherrier et al., 2012),Nrarp,
Dtx1, andDtx2were downregulated inBcl11b/mILC2s, further
supporting the idea that Bcl11b/ mILC2s acquire an ILC3
phenotype. Additionally, Bcl11b/ mILC2s exhibited a higher
abundance ofmRNAs for NKmarkers, such asCd244 andKlrb1b
(Figure 5A), usually upregulated in the absence of Bcl11b from
most T cells and progenitors (Avram and Califano, 2014).
Bcl11b/ mILC2s also upregulated several genes known to be
important for Treg cells, includingCtla4 and Il10 (Figure 5A) (Asse-
man et al., 1999; Read et al., 2000), suggesting that these cells
might acquire a suppressive phenotype. Taken together, these re-
sults demonstrate that, overall, Bcl11b sustains a large fraction of
the ILC2 genetic program and represses the ILC3 genetic pro-
gram in mILC2s, further substantiating the claim that Bcl11b/
mILC2s lose their genetic and functional identity.dependent and Intrinsic
MX-Rag1/Bcl11bF/Fcre-ERT2 and TMX-Rag1/ mice.
s of TMX-Rag1/Bcl11bF/Fcre-ERT2 (black) and TMX-Rag1/ (dashed) mice.
gs and mLNs of the indicated groups of mice. Data (n = 6) are representative of
and SILP of TMX-Rag2/Il2rg/ mice reconstituted with BM ILC2Ps
donor mice were not treated with TMX, which was only administered to the
D90+Sca-1+CD127+ population from the lungs of TMX-Rag2/Il2rg/ mice
ray shaded area represents the negative control.
t (I) in the LinCD90+Sca-1+CD127+ population in the lungs and SILP of the
eriments and are presented as mean ± SEM. Significance was determined by
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Figure 3. Bcl11b–/– mILC2s Respond to IL-23 Instead of IL-33
(A) BrdU incorporation in mILC2s from the lungs and mLNs of TMX-Bcl11bF/Fcre-ERT2 and TMX-wild-type control mice administered with either IL-23 (black),
IL-33 (dashed), or PBS (gray shaded area).
(B) Absolute numbers of mILC2s from the lungs and mLNs of the indicated groups of mice from the experiment in (A). Data (n = 5) are representative of two
independent experiments and are presented as mean ± SEM. Significance was determined by Student’s t test (*p% 0.05).
(C and D) Flow cytometry analysis of intracellular IL-22 versus IL-13 (C) and IL-17 versus IL-13 (D) in mILC2s from the mLNs of IL-33- or IL-23-treated
TMX-Bcl11bF/Fcre-ERT2 and TMX-wild-type control mice. Data (n = 4) are representative of three independent experiments.
See also Figure S4.Bcl11b Associates with Conserved Noncoding
Sequences at the Gfi1 and Ahr Loci, but Not with Gata3
or Rorc, in ILC2s
Given that Gfi1 was among the genes regulated by Bcl11b and
was recently found to control many of the genes changed in
the absence of Bcl11b, we reasoned that Bcl11b might exert360 Immunity 43, 354–368, August 18, 2015 ª2015 Elsevier Inc.its control through direct regulation of Gfi1. We thus designed
primers covering conserved noncoding sequences (CNSs)
from approximately 800 bp through the transcription start
site (TSS) (Yu¨cel et al., 2004). Using chromatin immunoprecipita-
tion (ChIP) assays, we found that Bcl11b bound to a region
located at413 through295 bp (Figures 6A and 6B), indicating
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that Bcl11b might regulate expression of Gfi1 by direct associa-
tion with its promoter. We further tested whether Bcl11b bound
to the Gata3 proximal promoter, given that we previously found
Bcl11b to associate with sequences at this location in Th17 cells
(Califano et al., 2014). In ILC2s, Bcl11b did not associate with the
Gata3 proximal promoter (Figure S7C), suggesting that the
reduced Gata3 in Bcl11b/ ILC2s is most likely a consequence
of lower Gfi1 expression. We further tested the association be-
tween Bcl11b and CNSs at the Ahr and Rorc loci. We found
that whereas Bcl11b did not significantly associate with any
CNSs at the Rorc locus (Figure S7D), it significantly associated
with aCNS located at5,447 through5,352 bp at theAhr locus
(Figure 6C). These results thus suggest that although changes
in Rorc might be a consequence of Gfi1 downregulation in
Bcl11b/ ILC2s, Bcl11b regulates Ahr directly. Taken together,
these results suggest that Bcl11b regulates the ILC2 lineage
through positive regulation of Gfi1, which maintains the ILC2
lineage by sustainingGata3, Il1rl1, and ILC2 cytokine expression
while also repressing expression of ILC3 genes through Rorc,
also downstream of Gfi1. In addition, Bcl11b also represses
the ILC3 program through direct repression of Ahr expression
and consequently its downstream genes.
Enforced Expression of Gfi1 in Bcl11b–/– ILC2s Restores
Gata3 and ST2 and Reduces Rorgt and IL-23R
We further wish to substantiate the hypothesis that down-
regulation of Gata3 and ST2 and the repression of Rorc in
Bcl11b/ ILC2s are a consequence of Gfi1’s regulation. We
thus retrovirally transduced Bcl11b/ ILC2s with Gfi1-NGFR
or control NGFR viruses (Figure 7A). Gfi1 transduction of
Bcl11b/ ILC2s resulted in upregulation of Gata3 and ST2
and reduction of Rorgt and IL-23R (Figures 7B and 7C). How-
ever, Rora was not upregulated as a result of Gfi1 transduction
(Figures 7B and 7C), suggesting that its regulation is through a
Gfi1-independent mechanism. These results demonstrate that
Bcl11b exerts its impact on Gata3, ST2, and Rorgt, but not
Rora, through Gfi1.
DISCUSSION
In this study, we have demonstrated that Bcl11b controls the
lineage identity and function of mILC2s but does not affectFigure 4. Bcl11b–/– ILC2s Promote Airway Infiltration of Neutrophils in R
(A) Flow cytometry analysis of intracellular IL-13, IL-5, IL-17, and IL-22 in L
TMX-Bcl11bF/Fcre-ERT2 (red) and TMX-wild-type control (black) mice. The gray
(B) Average frequency of cytokine-producing LinCD90+Sca-1+CD127+ ILC2s fro
type control (white) mice. Data (n = 6) are representative of two independent exp
Student’s t test (*p% 0.05).
(C) Absolute numbers of LinCD90+Sca-1+CD127+ ILC2s from the lungs of the in
(D) Absolute numbers of eosinophils (LymphCD11b+CD11cloLy6GSiglecF+) and
the indicated groups of mice were determined by flow cytometry analysis. Data (n
mean ± SEM. Significance was determined by Student’s t test (*p% 0.05).
(E) Mucus production was evaluated by Periodic acid–Schiff staining of lung tissue
Data are representative of three independent pairs. Scale bar represents 200 mm
(F) Bacterial colony-forming units from feces of C. rodentium-infected TMX-Rag1
day 5. Data (n = 4) are representative of two independent experiments and are
(*p% 0.05).
(G and H) Flow cytometry analysis of intracellular IL-17 versus IL-22 in mILC2s and
Bcl11bF/Fcre-ERT2 and TMX-Rag1/ mice on post-infection day 5. Data (n = 4)
362 Immunity 43, 354–368, August 18, 2015 ª2015 Elsevier Inc.ILC2 development. Bcl11b has been suggested to be a T-cell-
lineage-specific transcription factor that maintains T cell lineage
identity by repressing the genetic programs of innate cells
(Li et al., 2010a; Li et al., 2010b). In contrast to this notion, here
we report that Bcl11b is also highly expressed in mILC2s and
is essential in retaining mILC2 lineage fidelity by sustaining
expression of essential ILC2 transcription factors and by sup-
pressing key ILC3 transcription factors through an intrinsic
mechanism. As a consequence of these alterations, Bcl11b/
ILC2s downregulate critical ILC2 genes and derepress essential
ILC3 genes. Importantly, our study demonstrates that absence
of Bcl11b alters not only the genetic program of mILC2s but
also their functional program. Specifically, Bcl11b/ ILC2s
expand and respond to the allergen papain with an ILC3 func-
tional program, causing production of ILC3 cytokines and infil-
tration of neutrophils instead of eosinophils in the airways.
Our study positions Bcl11b in the hierarchy of transcription
factors that control the mILC2 program upstream of Gfi1,
Gata3, and Rora, but not of TCF-1. Considering that Gfi1 has
been demonstrated to regulate Gata3, and the fact that
Bcl11b did not associate with the Gata3 promoter but did bind
the Gfi1 promoter, it is likely that reduced Gfi1 caused the
decrease in Gata3 in the absence of Bcl11b. Additionally, rein-
troduction of Gfi1 in Bcl11b/ mILC2s restored Gata3 but did
not affect Rora, suggesting that Bcl11b regulates Rora indepen-
dently of Gfi1. Previous evidence demonstrating that Gfi1 does
not regulate Rora supports this idea (Spooner et al., 2013).
Furthermore, we did not detect a reduction in Rora mRNA after
Bcl11b removal, even though protein amounts were decreased,
suggesting that the regulation of Rora most likely occurs post-
transcriptionally. The ST2 subunit of the IL-33 receptor was
also reduced in the absence of Bcl11b, and this is most likely
related to diminished Gfi1 and Gata3, given that Il1rl1 expres-
sion is known to be regulated by Gata3 and Gfi1 (Hoyler et al.,
2012; Spooner et al., 2013; Yagi et al., 2014; Yang et al.,
2013). The reduction in ST2 most likely made Bcl11b/ ILC2s
respond inefficiently to IL-33; however, they expanded and pro-
duced ILC3 cytokines in response to IL-23. The ILC2 receptor
IL-17Rb, a subunit of IL-25R, remained unchanged, and
Bcl11b/ ILC2s expanded normally in response to IL-25. How-
ever, they failed to produce IL-13, supporting the idea of alter-
ations in factors controlling ILC2 cytokine production, such asesponse to Papain and Confer Increased Protection to C. rodentium
inCD90+Sca-1+CD127+ ILC2s from the lungs of papain- or PBS-treated
shaded area represents PBS-treated mice.
m the lungs of papain-treated TMX-Bcl11bF/Fcre-ERT2 (black) and TMX-wild-
eriments and are presented as mean ± SEM. Significance was determined by
dicated groups of mice.
neutrophils (LymphCD11b+CD11cloLy6G+SiglecF) in the lungs and BALF of
= 6) are representative of three independent experiments and are presented as
s of papain-treated TMX-Bcl11bF/Fcre-ERT2 and TMX-wild-type control mice.
.
/Bcl11bF/Fcre-ERT2 (black) and TMX-Rag1/ (white) mice on post-infection
presented as mean ± SEM. Significance was determined by Student’s t test
ILC3s from the mLNs (G) and SILP (H) of C. rodentium-infected TMX-Rag1/
are representative of two independent experiments.
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Figure 5. Bcl11b Sustains Expression of the ILC2 Program and Restricts Expression of the ILC3 Program in mILC2s
(A) RNA-seq analysis of mILC2s (LinCD90+Klrg1+) sorted from the mLNs of TMX-Bcl11bF/Fcre-ERT2 and TMX-wild-type control mice at steady state. Data are
shown as a scatter plot of log2 of FPKM (fragments per kilobase of transcript per million mapped reads) from Bcl11b
/ and wild-type ILC2s. Blue dots represent
downregulated genes, and red dots represent upregulated genes in Bcl11b/ ILC2s. Genes of interest are indicated andmarked in orange (downregulated) and
yellow (upregulated).
(B) qRT-PCR analysis of the indicated mRNAs from mILC2s from the lungs of TMX-Bcl11bF/Fcre-ERT2 and TMX-wild-type control mice. Data are representative
of four independent experiments with three mice per group and are presented as mean ± SEM. Significance was determined by Student’s t test (*p% 0.05). ns
indicates non-significant. Rorc p = 0.06; TCF7 p = 0.24.
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Figure 6. Bcl11b Associates with CNSs at
the Gfi1 and Ahr Loci
(A) ChIP by anti-Bcl11b antibodies (blue) or IgG
(Pink) of cross-linked nuclear extracts from sorted
LinCD90+Klrg1+ ILC2s expanded in vitro as
described in Supplemental Experimental Pro-
cedures. Chromatin immunoprecipitated DNAwas
amplified by qPCR with primers for the indicated
conserved regions in the Gfi1 promoter (Yu¨cel
et al., 2004) and expressed as a percentage of the
input. Data (n = 6) are representative of three in-
dependent experiments and are presented as
mean ± SEM. Significance was determined by
Student’s t test (*p% 0.05). Primer sequences are
provided in Figure S7E.
(B) A vista plot of the Ahr locus shows the CNSs
covering a region between11,000 bp through the
TSS (red triangle). Five sets of primers (1–5) were
designed for the conserved regions (pink peaks).
(C) Chromatin immunoprecipitated DNA was
amplified by qPCR with the five sets of primers for
the five indicated conserved regions (black tri-
angles). Data (n = 6) are representative of three
independent experiments and are presented as
mean ± SEM. Significance was determined by
Student’s t test (*p% 0.05). Primer sequences are
provided in Figure S7E.
See also Figure S7.Gata3, but intact proliferation abilities. Similar to what was
observed inGata3/ ILC2s (Yagi et al., 2014), Klrg1 was normal
in Bcl11b/ ILC2s. Therefore, mILC2s were maintained, but
they lost key features of ILC2 identity, as well as their function.
In this regard, different from Gata3/ ILC2s but similar to
Gfi1/ ILC2s (Hoyler et al., 2012; Spooner et al., 2013; Yagi
et al., 2014; Yang et al., 2013), Bcl11b/ ILC2s, including those
in the lungs, expressed the transcription factor Rorgt together
with IL-23R. However, different fromGfi1/ ILC2s, which failed
to respond to papain (Spooner et al., 2013), Bcl11b/ ILC2s
expanded but, rather than producing IL-5 and IL-13, produced
IL-17 and IL-22 and thus caused an ILC3-type inflammation
with increased airway neutrophils and reduced mucus produc-
tion. Gata3, ST2, Rorgt, and IL-23R were all restored after trans-
duction with Gfi1, suggesting that the genes encoding these364 Immunity 43, 354–368, August 18, 2015 ª2015 Elsevier Inc.proteins are most likely controlled by
Bcl11b through Gfi1. Rorc was almost
significantly upregulated in Bcl11b/
ILC2s, but we cannot exclude the possi-
bility that althoughRorcmight be partially
regulated by Bcl11b through the Gfi-
Sox4 axis, there might also be a Gfi1-in-
dependent, post-transcriptional mecha-
nism in place whereby Rorgt is regulated
in a manner dependent on Bcl11b. In
addition to regulating Gfi1 expression
directly, Bcl11b also associated with the
Ahr locus, and Ahr mRNA was highly
upregulated in the absence of Bcl11b.
Bcl11b/ ILC2s produced IL-22, known
to be controlled by Ahr in ILC3s (Qiu et al.,2012; Lee et al., 2012), which conferred enhanced resistance to
C. rodendium infection. Different from Bcl11b/ ILC2s, Gfi1/
ILC2s showed a minor but significant decrease in Ahr expres-
sion (Spooner et al., 2013), suggesting that although Gfi1 is
downstream of Bcl11b in mILC2s, there are some differences
between their regulatory functions. This could be due to the
fact that Gfi1/ ILC2s exhibit developmental defects and
therefore are not fully mILC2s, whereasBcl11b/ ILC2smature
normally from the ILC2Ps in the BM. Different from the other
transcription factors known to be critical for ILC2 lineage,
including TCF-1, Gfi1, Gata3, and Rora, Bcl11b is unique in
that it only controls mILC2s, given that it is very modestly ex-
pressed in BM ILC2Ps and thus does not affect their develop-
ment and/or maturation. The ILC2 transcriptional program mir-
rors the network found in developing thymocytes. Early Notch
A B
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Figure 7. Transduction with Gfi1 Retroviruses Re-establishes the ILC2 Phenotype and Restricts the ILC3 Phenotype in Bcl11b–/– ILC2s
(A) Flow cytometry analysis of the NGFR+ population in the Gfi1-NGFR- or NGFR-transduced lung LinCD90+Sca-1+CD127+ cells isolated from TMX-Rag1/
Bcl11bF/Fcre-ERT2 mice.
(B) Gata3, ST2, Rorgt, IL-23R, and Rora in NGFR+ LinCD90+Sca-1+CD127+ cells (Gfi1-NGFR [black] and NGFR [dashed]).
(C) Average MFI of Gata3, ST2, Rorgt, IL-23R, and Rora in NGFR+ LinCD90+Sca-1+CD127+ cells (Gfi1-NGFR [black] or NGFR [white]). Data (n = 4) are
representative of two independent experiments and are presented as mean ± SEM. Significance was determined by Student’s t test (*p% 0.05).signaling induces the expression of TCF-1, which promotes up-
regulation of Gata3 (Weber et al., 2011). Notch signaling, TCF-1,
and Gata3 synergistically promote the induction of Bcl11b
expression, which further restricts alternative lineage fates
and solidifies T cell commitment (Garcı´a-Ojeda et al., 2013; Li
et al., 2010a; Weber et al., 2011). In DN3 thymocytes, deficiency
of Bcl11b causes reduction in Tcf7 and Gata3 transcripts,
indicating that in later stages of development, Bcl11b sustains
the expression of these T-cell-determining factors (Li et al.,
2010a; Li et al., 2010b). In ILC2s, Bcl11b seems to be expressed
after the induction of TCF-1, Gata3, and Gfi1 and ILC2P fate
specification. However, once it is expressed, Bcl11b is required
to sustain expression of Gfi1 in mILC2s, similarly to how it
sustains Gata3 and Tcf7 expression in DN3 thymocytes. Im-
portantly, unlike thymocytes, Bcl11b/ ILC2s derepress the
critical ILC3 transcription factors Rorgt and Ahr and functionally
respond similarly to ILC3s. How expression of Bcl11b is induced
in ILC2s remains to be established.Our analysis of mRNAs in Bcl11b/ ILC2s was conducted
on steady-state ILC2s and not after culture with ILC2-stimulating
cytokines, such as IL-25. This is especially important because
recent reports suggest that IL-25 treatment can stimulate
the proliferation of an ILC2-like cell that does not express ST2,
possesses multipotency, and can acquire IL-17-producing
capabilities (Huang et al., 2015; Saenz et al., 2010). Whether
Bcl11b regulates the phenotype of these ILC2-like cells remains
to be determined. In addition to upregulating ILC3 functional
genes, Bcl11b/ ILC2s also upregulated several genes associ-
ated with the suppressive phenotype of Treg cells, including
Ctla4 and Il10 (Asseman et al., 1999; Read et al., 2000). ILC3s
areknown to inhibitCD4+Tcell activation throughantigenpresen-
tation without costimulation. MHC class II genes involved in this
process (Hepworth et al., 2013) were upregulated in Bcl11b/
ILC2s. Whether Bcl11b/ ILC2s contribute to the suppression
of the T-cell-mediated immune responses, resulting in protection
from inflammation and autoimmunity, remains to be established.Immunity 43, 354–368, August 18, 2015 ª2015 Elsevier Inc. 365
In conclusion, our studies extend Bcl11b’s role beyond T cell
lineage identity by demonstrating its ability to control mILC2 fate
by maintaining expression of essential ILC2 transcription factors
andguarding fromexpressionof critical ILC3 transcription factors.
EXPERIMENTAL PROCEDURES
Mice
Bcl11bF/F were previously described (Albu et al., 2007; Albu et al., 2011; Cal-
ifano et al., 2014; Li et al., 2010b; Zhang et al., 2010) and bred with cre-ERT2
mice and further with Rag1/ mice. cre-ERT2 and Rag1/ mice were from
the Jackson Laboratories, and Rag2/Il2rg/ mice were from Taconic Bio-
sciences. All mice were housed in pathogen-free conditions. All experiments
were conducted on 7- to 12-week-old mice.
Study Approval
All mouse procedures were approved by the Albany Medical Center Institu-
tional Animal Care and Use Committee.
Tamoxifen Treatment for cre-ERT2 Activation
Mice were given intraperitoneal injections of 200 mg tamoxifen for 5 consecu-
tive days. Seven to eight days after the last injection, mice were sacrificed and
analyzed.
Papain-Induced Inflammation
Mice were intranasally administered 10 mg papain or PBS on days 0–2 and
further euthanized on day 3. Lungs and BALF were collected and processed
as described in the Supplemental Experimental Procedures, and populations
were analyzed by flow cytometry. Additionally, lung tissue was fixed in 10%
paraformaldehyde and embedded in paraffin, and sections were stained
with Periodic acid–Schiff.
C. rodentium Infection and Bacterial Burden
Mice were infected with C. rodentium via oral gavage with 1010 colony-forming
units in 200 ml PBS. Fecal pellets were collected, weighed, and then homoge-
nized in sterile PBS. Serially diluted homogenates were plated on MacConkey
agar plates and incubated at 37C. Colonies were counted after 24 hr.
Tissue Digestion for Release of Cells
Lymphocytes were isolated frommLNs, lung, small intestine, and BM. For lam-
ina propria (LP) lymphocyte isolation, tissue was digested for 90 min at 37C in
0.75 ml complete media (CM) containing 100 mg/ml collagenase D (Roche),
1 mg/ml dispase II (Invitrogen), and 0.2mg/ml DNase (Roche). LP lymphocytes
were further washed with CM and enriched by 33% Percoll gradient centrifu-
gation. For lung lymphocyte isolation, lungswere perfused by injection of 10ml
PBS into the right ventricle of the heart. Further, lung tissue was incubated at
37C for 1 hr in CM containing 1 mg/ml collagenase D (Roche) and 0.15 mg/ml
DNase (Roche). Cells were washed, filtered through a 40-mm cell strainer, and
treated with red blood cell lysis buffer. For BALF collection, the mouse lungs
were lavaged three times with 1 ml of PBS, and cells were centrifuged at
350 3 g for 5 min and stained for flow cytometry.
mILC2 Isolation
LinCD90+CD127+Sca-1+Klrg1hi ILC2s were enriched from the lungs of
Rag1/ mice with the Dynabeads FlowComp Mouse Pan T (CD90.2) Kit
(Invitrogen) and subsequently sorted on a FACSAria II (BD Biosciences).
mILC Identification
In brief, the mILC populations were identified as previously described (Hoyler
et al., 2012; Monticelli et al., 2011) by gating first on CD90+ cells negative
for CD3, CD5, CD19, CD11c, CD11b, TCRb, and NK1.1 and then on CD127+
Sca-1+ cells. The ILC2s and ILC3s were differentiated on the basis of high
and low expression of Klrg1, respectively.
Retroviral Transduction of ILCs
Lung mILC2s were enriched from TMX-Rag1/Bcl11bF/Fcre-ERT2 mice with
the Dynabeads FlowCompMouse Pan T (CD90.2) Kit (Invitrogen) and cultured366 Immunity 43, 354–368, August 18, 2015 ª2015 Elsevier Inc.for 2 days in DMEM plus 20% fetal bovine serum, 1 U/ml IL-2, 20 ng/ml IL-7,
and 20 ng/ml IL-33. For retrovirus generation, Plat E cells were transfected
with Gfi1-NGFR or NGFR retroviral vectors (Del Real and Rothenberg, 2013).
Retroviral supernatants were collected 2 days after transfection and supple-
mented with 4 mg/ml polybrene, and ILC2s were infected by spinoculation
as previously described (Cismasiu et al., 2006). ILC2s were evaluated for
NGFR, ST2, Gata3, Rora, IL-23R, and Rorgt by fluorescence-activated cell
sorting 5 days after transduction.
RNA-Seq Analysis
LinCD90+KLRG1+ mILC2s were sorted from the mLNs of TMX-Bcl11bF/Fcre-
ERT2 and TMX-wild-type controls. RNA was extracted with the RNeasy
Plus Micro Kit (QIAGEN), and RNA-seq experiments were performed.
Sequenced reads were cleaned according to a rigorous pre-processing
workflow (Trimmomatic-0.32) before being mapped to the mouse genome
(mm10, UCSC Genome Browser) with SHRiMP2.2.3. Gene expression
was measured by FPKM (fragments per kilobase of transcript per million
mapped reads). Cufflinks2.0.2 was used to perform differential expres-
sion analysis with a false-discovery rate cutoff of 0.05 (95% confidence
interval).
qRT-PCR
RNA was extracted from sorted lung mILC2s (LinCD90+CD127+Sca-1+
KLRg1hi) with the RNeasy Plus Micro Kit and Omniscript RT Kit (QIAGEN).
qRT-PCR was conducted as previously described (Cismasiu et al., 2006).
The primers for qRT-PCR were chosen to extend products under 200 bp
without the formation of primer dimmers and to cross introns. Primer se-
quences are available upon request. The relative abundance of each message
was normalized to actin and calculated as follows: 2  (Ct gene  Ct actin),
where Ct represents the threshold cycle for each transcript.
Statistical Analysis
Differences between TMX-Bcl11bF/Fcre-ERT2 mice and TMX-wild-type mice
were determined by a two-tailed Student’s t test (unequal variance). p %
0.05 was considered significant. All values were expressed as mean ± SEM.
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